Method for efficiently producing glucose oxidase in aspergillus niger through synergistic high expression of GOD and CAT
By constructing and introducing recombinant vectors, high expression and secretion of GOD and CAT in Aspergillus niger are achieved, the problems of low expression and high production cost are solved, and the fermentation efficiency and industrial production efficiency of sodium gluconate are significantly improved.
Patent Information
- Application Number
- CN202411141663.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-08
AI Technical Summary
In the prior art, the expression levels of glucose oxidase GOD and catalase CAT are relatively low, resulting in limited sugar consumption rate of Aspergillus niger in organic acid fermentation, and high industrial production costs, and lack of recombination that can express GOD and CAT efficiently at the same time. microorganism.
By constructing the recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT, the host strain of Aspergillus niger was introduced, and high expression and large secretion of GOD and CAT were achieved by antibiotic pressure screening. Shorten the fermentation cycle of sodium gluconate.
It significantly improves the enzyme activity of GOD and CAT, improves the industrial production efficiency of sodium gluconate, reduces production costs, and lays the foundation for industrial production.
Smart Images

Figure CN118909991A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of bioengineering, and more particularly to a method for efficiently producing glucose oxidase in Aspergillus niger by synergistically highly expressing GOD and CAT. Background Art
[0002] Glucose oxidase GOD can catalyze the conversion of glucose to gluconic acid in microorganisms. Since glucose is oxidized to gluconic acid under the action of GOD, hydrogen peroxide is produced in the process. Hydrogen peroxide has strong oxidizing properties and has a certain toxic effect on GOD. Therefore, catalase CAT plays a very important role. It can quickly decompose hydrogen peroxide, and the products are water and oxygen, so that GOD continues to play a role, and can supplement some oxygen, so that the oxidation reaction can continue.
[0003] Hebei Institute of Microbiology Co., Ltd. optimized the expression of glucose oxidase in Pichia pastoris through the combined strategy of transforming Aspergillus niger glucose oxidase, and obtained a Pichia pastoris engineered strain that efficiently and stably expresses glucose oxidase, and the enzyme production level in a 10L fermenter can reach 1198U / mL. Liao Zhaomin used Pichia pastoris as the host to construct a recombinant strain of glucose oxidase, optimized the fermentation conditions at the shake flask level, and finally co-expressed His4 in a 30L fermenter to make the GOD enzyme activity reach 461U / mL. Although the above studies have successfully achieved heterologous expression of glucose oxidase in various expression hosts, problems such as low expression level and high cost of industrial production have not been properly solved. In addition, GOD usually forms an oxidoreductase system with CAT. Therefore, in the production of organic acid fermentation, it is more urgent to study and construct a recombinant microorganism that can simultaneously overexpress GOD and CAT. In addition, Aspergillus niger CAT mainly exists in cells, which may be the main factor that prevents the sugar consumption rate from being further increased.
[0004] Therefore, providing a method for synergistically high-expressing GOD and CAT in Aspergillus niger to efficiently produce glucose oxidase is an urgent problem to be solved by those skilled in the art. Summary of the invention
[0005] In view of this, the present invention provides a method for efficiently producing glucose oxidase in Aspergillus niger by synergistically highly expressing GOD and CAT, transforming the Aspergillus niger FG-2 strain producing sodium gluconate, enhancing the expression of CAT and GOD at the same time, realizing a large amount of extracellular secretion of GOD and CAT by the engineered bacteria, further shortening the fermentation cycle of sodium gluconate, and having a positive promoting effect on the industrial production of sodium gluconate.
[0006] In order to achieve the above object, the present invention adopts the following technical solution:
[0007] A method for efficiently producing glucose oxidase in Aspergillus niger by synergistically high-expressing GOD and CAT, the specific steps are as follows:
[0008] (1) Construction of recombinant vectors pAN7-1-BleoR and pAN7-1-G418
[0009] ① Using the BleoR gene fragment as a template and primers BleoR-f / r for PCR amplification, the target gene fragment BleoR was obtained; using the G418 gene fragment as a template and primers G418-f / r for PCR amplification, the target gene fragment G418 was obtained;
[0010] The BleoR gene fragment is shown in SEQ ID NO.9; the G418 gene fragment is shown in SEQ ID NO.10;
[0011] ②Using plasmid pAN7-1 as template, PCR amplification was performed using primers BleoR-zai-f / r to obtain the vector backbone pAN7-1 corresponding to BleoR; PCR amplification was performed using G418-zai-f / r to obtain the vector backbone pAN7-1 corresponding to G418;
[0012] ③ The target gene fragment obtained in step ① and the vector backbone obtained in step ② were digested with the rapid endonuclease DpnI respectively, and then cloned and connected in one step to obtain the recombinant vectors pAN7-1-BleoR and pAN7-1-G418;
[0013] (2) Construction of recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT
[0014] ①Using the genome extracted from Aspergillus niger FG-2 as a template, PCR amplification was performed using primers GOD-f / r to obtain the GOD gene fragment;
[0015] ② Using the recombinant vectors pAN7-1-BleoR and pAN7-1-G418 obtained in step (1) as templates, PCR amplification was performed using primers GOD-zai-f / r to obtain vector backbones pAN7-1-BleoR and pAN7-1-G418;
[0016] ③ The GOD gene fragment obtained in step ① and the linearized vector obtained in step ② were digested with the rapid endonuclease DpnI, and then cloned and connected in one step to obtain the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD;
[0017] ④ Using the recombinant plasmids pAN7-1-BleoR-GOD and pAN7-1-G418-GOD as templates, PCR amplification was performed using primers p2a-f / r to obtain linearized recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD;
[0018] ⑤ The linearized recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD obtained in step ④ were digested with the rapid endonuclease DpnI, and the linearized recombinant vectors were self-ligated by a one-step cloning method to obtain pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a;
[0019] ⑥Using the genome of Aspergillus niger FG-2 as a template, PCR amplification was performed using primers CAT-f / r to obtain the CAT gene fragment;
[0020] ⑦ Using the recombinant plasmids pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a as templates, PCR amplification was performed using primers CAT-zai-f / r to obtain the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD to which the CAT gene fragments to be connected;
[0021] ⑧ The recovered vector backbone and gene fragment were digested with the rapid endonuclease DpnI, and the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD were connected with the CAT gene fragment respectively by a one-step cloning method to obtain the recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT;
[0022] (3) Using Aspergillus niger FG-2 as the starting strain, the recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT were expressed
[0023] The recombinant plasmids pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT were transformed into FG-2, respectively, and the genetically engineered strains FG-2-BleoR-GOD-CAT and FG-2-G418-GOD-CAT were obtained by antibiotic pressure screening.
[0024] Further, the primer sequences used in step (1) are as follows:
[0025] BleoR-zai-f:5'-tgaagtagatgccgaccgcgggatc-3' SEQ ID NO.
[0026] BleoR-zai-r:5'-catggtgatgtctgctcaagcggggt-3' SEQ ID NO.2;
[0027] G418-zai-f:5'-taaagtagatgccgaccgcgggatc-3':SEQ ID NO.
[0028] G418-zai-r:5'-catggtgatgtctgctcaagcggggt-3' SEQ ID NO.4;
[0029] BleoR-f:5'-gagcagacatcaccatggccaagttgaccagtgccgttccggt-3' SEQ IDNO.5;
[0030] BleoR-r:5'-ggtcggcatctacttcagtcctgctcctcggccacgaagt-3' SEQ ID NO.6;
[0031] G418-f:5'-gagcagacatcaccatgagccatsttcaacggga-3':SEQ ID NO.7;
[0032] G418-r:5'-ggtcggcatctactttagaaaaactcatcgagcatcaaat-3' SEQ ID NO.
[0033] To be sure, the (2) snowflakes are covered:
[0034] GOD-f:5'-ctctttcttttcccctgccacactacatcaggagcaatg-3' SEQ ID NO.11;
[0035] GOD-r:5'-aatatactgaagatctgcatagaagcgtagtcctccaaaatag-3':SEQ ID NO.
[0036] GOD-zai-f:5'-cagatcttcagtatattcatcttcccatcca-3' SEQ ID NO.13;
[0037] GOD-zai-r: 5'-caggggaaaagaaagagaaaagaaaagagca-3'; SEQ ID NO.14;
[0038] p2a-f: 5'-ctgaagcaggccggcgacgtggaggagaaccccggccccatcttcagtatattcatctt-3'; SEQ ID NO.15;
[0039] p2a-r: 5'-tcgccggcctgcttcagcagggagaagttggtggcctgcactagaagcgtagtcctc-3'; SEQ ID NO.16;
[0040] CAT-f: 5'-agaaccccggccccatgggcaaggacgatcaacccaagac-3'; SEQ ID NO. 18;
[0041] CAT-r: 5'-aatatactgaagatttacagacgagcagacttggagtgg-3'; SEQ ID NO.19;
[0042] CAT-zai-f: 5'-taaatcttcagtatattcatcttccc-3'; SEQ ID NO. 20;
[0043] CAT-zai-r: 5'-catggggccggggttctcct-3'; SEQ ID NO. 21.
[0044] Furthermore, the antibiotic pressure screening in step (3) is screening with 50-1000 μg / ml bleomycin or geneticin.
[0045] It can be seen from the above technical scheme that, compared with the prior art, the present invention discloses a method for efficiently producing glucose oxidase in Aspergillus niger by synergistically highly expressing GOD and CAT. First, a recombinant plasmid containing the BleoR / G418 resistance gene is constructed, and then the GOD, p2a and CAT genes are introduced into the Aspergillus niger host strain. A large amount of GOD secretion is achieved through an antibiotic pressure (50-1000ug / ml) screening method, and the enzyme activity is greatly improved. This lays a foundation for further improving the industrial production of sodium gluconate. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.
[0047] Figure 1 The accompanying drawings are the PCR verification results of the recombinant plasmid of the present invention;
[0048] Among them, M: 10pb Marker; Lane 1: pAN7-1-BleoR plasmid; Lane 2: pAN7-1-BleoR plasmid bleor fragment verification; Lane 3: BleoR fragment control; Lane 4: pAN7-1-BleoR plasmid pAN7-1 vector verification; Lane 5: pAN7-1 vector control; Lane 6: pAN7-1-G418 plasmid; Lane 7: pAN7-1-G418 plasmid G418 fragment verification; Lane 8: G418 fragment control; Lane 9: pAN7-1-G418 plasmid pAN7-1 vector verification; Lane 10: pAN7-1 vector control;
[0049] Figure 2 The accompanying drawing is a verification of the pAN7-1-BleoR-GOD plasmid of the present invention;
[0050] Among them, M: 5000bp Marker; Lane 1-2: pAN7-1-BleoR-GOD plasmid GOD fragment verification;
[0051] Figure 3 The accompanying drawing is a verification of the pAN7-1-G418-GOD plasmid of the present invention;
[0052] Among them, M: 5000bp Marker; Lanes 1-3: pAN7-1-G418-GOD plasmid GOD fragment verification;
[0053] Figure 4 The accompanying drawings are the PCR verification results of the recombinant plasmid of the present invention;
[0054] Among them, M: 5000bp Marker; Lane 1: pAN7-1-BleoR-GOD-p2a plasmid p2a fragment verification; Lane 2: pAN7-1-G418-GOD-p2a plasmid p2a fragment verification;
[0055] Figure 5 The accompanying drawings are the PCR verification results of the recombinant plasmid of the present invention;
[0056] Among them, M: 5000 bp Marker; Lane 1-2: verification of the CAT fragment of the pAN7-1-BleoR-GOD-p2a-CAT plasmid; Lane 3: verification of the CAT fragment of the pAN7-1-G418-GOD-p2a-CAT plasmid. DETAILED DESCRIPTION
[0057] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0058] Example 1 Construction of recombinant vectors pAN7-1-BleoR and pAN7-1-G418
[0059] (1) Obtaining vector backbone and gene fragments: Using plasmid pAN7-1 as a template, PCR amplification was performed using primers BleoR-zai-f / r to obtain the vector backbone pAN7-1 corresponding to BleoR; using G418-zai-f / r to perform PCR amplification to obtain the vector backbone pAN7-1 corresponding to G418; using bleomycin gene fragment BleoR (sequence as shown in SEQ ID NO.9) as a template, PCR amplification was performed using primers BleoR-f / r to obtain the target gene fragment BleoR; using geneticin gene fragment G418 (sequence as shown in SEQ ID NO.10) as a template, PCR amplification was performed using primers G418-f / r to obtain the target gene fragment G418. The primer sequences used are as follows:
[0060] BleoR-zai-f: 5'-tgaagtagatgccgaccgcgggatc-3'; SEQ ID NO.1;
[0061] BleoR-zai-r: 5'-catggtgatgtctgctcaagcggggt-3'; SEQ ID NO.2;
[0062] G418-zai-f: 5'-taaagtagatgccgaccgcgggatc-3'; SEQ ID NO.3;
[0063] G418-zai-r: 5'-catggtgatgtctgctcaagcggggt-3'; SEQ ID NO.4;
[0064] BleoR-f: 5’-gagcagacatcaccatggccaagttgaccagtgccgttccggt-3’; SEQ ID NO.5;
[0065] BleoR-r: 5’-ggtcggcatctacttcagtcctgctcctcggccacgaagt-3’; SEQ ID NO.6;
[0066] G418-f: 5’-gagcagacatcaccatgagccatsttcaacggga-3’; SEQ ID NO.7;
[0067] G418-r: 5’-ggtcggcatctactttagaaaaactcatcgagcatcaaat-3’; SEQ ID NO.8;
[0068] The BleoR gene sequence is as follows:
[0069] atggccaagttgaccagtgccgttccggtgctcaccgcgcgcgacgtcgccggagcggtcgagttctggacc
[0070] gaccggctcgggttctcccgggacttcgtggaggacgacttcgccggtgtggtccgggacgacgtgaccctgttcatc
[0071] agcgcggtccaggaccaggtggtgccggacaacaccctggcctgggtgtgggtgcgcggcctggacgagctgtac
[0072] gccgagtggtcggaggtcgtgtccacgaacttccgggacgcctccgggccggccatgaccgagatcggcgagcag
[0073] ccgtgggggcgggagttcgccctgcgcgacccggccggcaactgcgtgcacttcgtggccgaggagcaggactg
[0074] a; SEQ ID NO.9.
[0075] The G418 gene sequence is as follows:
[0076] atgagccatattcaacgggaaacgtcttgctcgaggccgcgattaaattccaacatggatgctgatttatatgggt
[0077] ataaatgggctcgcgataatgtcgggcaatcaggtgcgacaatctatcgattgtatgggaagcccgatgcgccagagt
[0078] tgtttctgaaacatggcaaaggtagcgttgccaatgatgttacagatgagatggtcagactaaactggctgacggaattt
[0079] atgcctcttccgaccatcaagcattttatccgtactcctgatgatgcatggttactcaccactgcgatccccgggaaaaca
[0080] gcattccaggtattagaagaatatcctgattcaggtgaaaatattgttgatgcgctggcagtgttcctgcgccggttgcatt
[0081] cgattcctgtttgtaattgtccttttaacagcgatcgcgtatttcgtctcgctcaggcgcaatcacgaatgaataacggtttg
[0082] gttgatgcgagtgattttgatgacgagcgtaatggctggcctgttgaacaagtctggaaagaaatgcataagcttttgcc
[0083] attctcaccggattcagtcgtcactcatggtgatttctcacttgataaccttatttttgacgaggggaaattaataggttgtatt
[0084] gatgttggacgagtcggaatcgcagaccgataccaggatcttgccatcctatggaactgcctcggtgagttttctccttc
[0085] attacagaaacggctttttcaaaaatatggtattgataatcctgatatgaataaattgcagtttcatttgatgctcgatgagttt
[0086] ttctaa; SEQ ID NO.10.
[0087] PCR reaction system: 2× PrimeSTARMax DNA Polymerase 25μL; Primer-F (10μM) 2μL; Primer-R (10μM) 2μL; Template 1μL; ddH 2 Add HO to make up to 50 μL.
[0088] PCR reaction program: 98℃ pre-denaturation for 3min; 98℃ denaturation for 15s, 60℃ annealing for 15s, 72℃ extension for 15s / kb, 34 cycles; 72℃ extension for 5min; 4℃ insulation. Product recovery was performed after verification.
[0089] (2) Connection of vector backbone and gene fragment: The recovered vector backbone and gene fragment were digested with the rapid endonuclease DpnI, and the corresponding vector backbone pAN7-1 recovered after digestion was recombined with the target gene fragments BleoR and G418 respectively using Vazyme's ClonExpress II One Step Cloning Kit-C112. The recombinant products were then transformed into E. coli DH5α competent cells and coated with 1‰ Amp + LB plates were plated and cultured overnight at 37°C. Two single colonies were picked and plasmids were extracted. Plasmids were extracted using the DiaSpin column plasmid DNA small-scale extraction kit. The specific steps were referred to the instruction manual. The extracted plasmids were verified by PCR using primers BleoR-f / r and G418-f / r, respectively. The results are shown in Figure 1 The size of the BleoR gene is 375bp, the size of the G418 gene is 816bp, and the size of the pAN7-1 vector is 5736bp, so the size of the recombinant vector pAN7-1-BleoR is 6111bp; the size of the recombinant vector pAN7-1-G418 is 6552bp. The PCR verification results showed that the two single colonies picked were correct, so they were saved.
[0090] Example 2
[0091] Construction of recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT
[0092] (1) Obtaining the vector backbone pAN7-1-BleoR and pAN7-1-G418 and the gene fragment GOD: The genome extracted from Aspergillus niger FG-2 was used as a template and PCR amplified using primers GOD-f / r to obtain the GOD gene fragment. The recombinant vectors pAN7-1-BleoR and pAN7-1-G418 obtained in Example 1 were used as templates and PCR amplified using primers GOD-zai-f / r to obtain the vector backbones pAN7-1-BleoR and pAN7-1-G418 for connecting the target gene GOD. The primer sequences used are as follows:
[0093] GOD-f: 5'-ctctttcttttcccctgccacactacatcaggagcaatg-3'; SEQ ID NO.11;
[0094] GOD-r: 5'-aatatactgaagatctgcatagaagcgtagtcctccaaaatag-3'; SEQ ID NO. 12;
[0095] GOD-zai-f: 5'-cagatcttcagtatattcatcttcccatcca-3'; SEQ ID NO.13;
[0096] GOD-zai-r: 5'-caggggaaaagaaagagaaaagaaaagagca-3'; SEQ ID NO. 14.
[0097] PCR reaction system: 2× PrimeSTARMax DNA Polymerase 25μL; Primer-F (10μM) 2μL; Primer-R (10μM) 2μL; Template 1μL; ddH 2 Add HO to make up to 50 μL.
[0098] PCR reaction program: 98°C pre-denaturation for 3 min; 98°C denaturation for 15 s, 58°C annealing for 15 s, 72°C extension for 15 s / kb, 34 cycles; 72°C extension for 5 min; 4°C insulation. The above PCR products were recovered after electrophoresis verification.
[0099] (2) Ligation of the vector backbone pAN7-1-BleoR and pAN7-1-G418 with the gene fragment GOD: The recovered vector backbone and gene fragment were digested with the rapid endonuclease DpnI, and the recovered target gene fragment GOD was recombined with the vector backbone pAN7-1-BleoR and pAN7-1-G418 respectively by a one-step cloning method. The recombinant products were then transformed into E. coli TR07 competent cells and coated with 1‰ Amp + LB plates were plated and cultured overnight at 37°C. All single colonies were picked and colony PCR was performed using primers GOD-f / r to amplify the GOD gene sequence for verification. The results are shown in Figure 2 , Figure 3 The size of the GOD gene fragment was 1767 bp. Plasmids were extracted from the correct single colonies verified by PCR and preserved. The recombinant plasmids were named pAN7-1-BleoR-GOD and pAN7-1-G418-GOD, respectively.
[0100] (3) Introducing the short sequence p2a (as shown in SEQ ID NO. 17) into the recombinant plasmids pAN7-1-BleoR-GOD and pAN7-1-G418-GOD: Using the recombinant plasmids pAN7-1-BleoR-GOD and pAN7-1-G418-GOD as templates, PCR amplification was performed using primers p2a-f / r to obtain linearized recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD. The primers and gene sequences used are as follows:
[0101] p2a-f: 5'-ctgaagcaggccggcgacgtggaggagaaccccggccccatcttcagtatattcatctt-3'; SEQ ID NO.15;
[0102] p2a-r: 5'-tcgccggcctgcttcagcagggagaagttggtggcctgcactagaagcgtagtcctc-3'; SEQ ID NO. 16.
[0103] p2a: 5-gccaccaacttctccctgctgaagcaggccggcgacgtggaggagaaccccggcccc-3'; SEQ ID NO. 17.
[0104] PCR reaction system: 2× PrimeSTARMax DNA Polymerase 25μL; Primer-F (10μM) 2μL; Primer-R (10μM) 2μL; Template 1μL; ddH2 Add HO to make up to 50 μL.
[0105] PCR reaction program: 98°C pre-denaturation for 3 min; 98°C denaturation for 15 s, 55°C annealing for 15 s, 72°C extension for 15 s / kb, 34 cycles; 72°C extension for 5 min; 4°C insulation. The above PCR products were recovered after electrophoresis verification.
[0106] The recovered vector backbone was digested with the fast endonuclease DpnI, and the recovered linearized recombinant vector was self-ligated by a one-step cloning method, and the short sequence p2a was introduced using the homology arm. The ligation products were transformed into E.coli TR07 competent cells and then coated with 1‰ Amp + LB plates were plated and cultured overnight at 37°C. Two single colonies were picked and the p2a gene sequence was verified by amplifying the plasmid using GOD-f and CAT-zai-r primers. The results are shown in Figure 4 The length of p2a sequence was 57 bp. Plasmids were extracted from single colonies verified by PCR and preserved. The recombinant plasmids were named pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a.
[0107] (4) Connection of recombinant plasmids pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a with CAT fragments: Using recombinant plasmids pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a as templates, PCR amplification was performed using primers CAT-zai-f / r to obtain recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD to be connected with the CAT gene fragment. Using the genome of Aspergillus niger FG-2 as a template, PCR amplification was performed using primers CAT-f / r to obtain the CAT gene fragment. The primer sequences used are as follows:
[0108] CAT-f: 5'-agaaccccggccccatgggcaaggacgatcaacccaagac-3'; SEQ ID NO. 18;
[0109] CAT-r: 5'-aatatactgaagatttacagacgagcagacttggagtgg-3'; SEQ ID NO.19;
[0110] CAT-zai-f: 5'-taaatcttcagtatattcatcttccc-3'; SEQ ID NO. 20;
[0111] CAT-zai-r: 5'-catggggccggggttctcct-3'; SEQ ID NO. 21.
[0112] PCR reaction system: 2× PrimeSTARMax DNA Polymerase 25μL; Primer-F (10μM) 2μL; Primer-R (10μM) 2μL; Template 1μL; ddH 2 Add HO to make up to 50 μL.
[0113] PCR reaction program: 98°C pre-denaturation for 3 min; 98°C denaturation for 15 s, 55°C annealing for 15 s, 72°C extension for 15 s / kb, 34 cycles; 72°C extension for 5 min; 4°C insulation. The above PCR products were recovered after electrophoresis verification.
[0114] The recovered vector backbone and gene fragment were digested with the rapid endonuclease DpnI, and the recombinant vector and gene fragment were connected by a one-step cloning method. The connection product was transformed into E. coli DH5α competent cells and then coated with 1‰ Amp + LB plates were plated and cultured overnight at 37°C. Two single colonies were picked and plasmids were extracted. The CAT gene sequence was amplified using CAT-f / r for verification. The results are shown in Figure 5 The length of CAT sequence was 1506 bp. Plasmids were extracted from single colonies verified by PCR and preserved. The recombinant plasmids were named pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT, respectively.
[0115] Example 3 Construction of genetically engineered strains of Aspergillus niger
[0116] (1) Construction of Aspergillus niger protoplasts: CYM medium was inoculated with spores from FG-2 and cultured at 35°C until a large number of mycelial balls were grown. The culture solution was filtered through eight layers of gauze to obtain mycelial balls, which were washed twice with 1M sorbitol solution and then enzymatically hydrolyzed. The enzymatic hydrolyzate solution consisted of 1% cellulase + 1% snail enzyme + 0.1% lysozyme. The three enzymes were purchased from Solarbio Company, wherein the cellulase activity was ≥3 units / ml and the lysozyme activity was ≥2 ku / mg. According to the wet weight of mycelial balls, 10 ml of enzymatic hydrolyzate solution was added to each 1 g of mycelial balls, and enzymatic hydrolysis was carried out in a shaker at 35°C and 150 rpm for 2.5 h. After the enzymatic hydrolysis was completed, it was filtered through 4 layers of gauze and centrifuged at 10°C and 10,000 rpm for 10 minutes. The precipitate was washed twice with sorbitol solution and resuspended with 1×STC solution to obtain Aspergillus niger protoplasts. After aliquoting, it was stored in a refrigerator at -80°C.
[0117] (2) Obtaining genetically engineered strains of Aspergillus niger
[0118] Chemical transformation method: plasmid diluted to 10ng / μl, take 10μl, mix with 100μl Aspergillus niger protoplasts, then add 200μl 60% PEG solution and mix, ice bath for 20min, add 2ml PEG after ice bath, mix at room temperature and place for 10min, then mix with 4ml STC and 4ml preheated upper layer non-resistance medium, pour on the lower layer resistance medium plate, and culture at 35℃. Upper layer non-resistance medium: CYM solid medium; lower layer resistance medium: CYM solid medium with final concentration of 50μg / ml bleomycin / geneticin; STC: 21.68g sorbitol, 1ml 1M tris-hcl (ph7.5-8), 10ml 1M calcium chloride, fixed volume 100ml.
[0119] Using the chemical transformation method, the successfully verified recombinant plasmids pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT were respectively transformed into the Aspergillus niger host FG-2, and the genetically engineered strains FG-2-BleoR-GOD-CAT and FG-2-G418-GOD-CAT were obtained by screening the corresponding resistance of the transformants (50-1000 μg / ml bleomycin / geneticin).
[0120] Example 4 Validation of genetically engineered strains at shake flask level
[0121] The above recombinant strains and wild-type FG-2 strain were selected (three transformants were screened at each concentration), and their spore suspensions were diluted to a concentration of 1.3×10 7 The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%. The inoculum size was 10%.
[0122] GOD and CAT enzyme activity determination: Take 1mL of fermentation broth in a 1.5mL centrifuge tube, centrifuge at 10000rpm, 4℃ for 5min, take the supernatant as the sample for determination of extracellular GOD or CAT enzyme activity, and determine GOD enzyme activity by colorimetry; determine CAT enzyme activity by sodium thiosulfate titration. The test results are shown in Table 1-2.
[0123] Table 1 Determination of GOD and CAT enzyme activities of bleomycin-resistant strains
[0124]
[0125] Table 2 Determination of GOD and CAT enzyme activities of geneticin-resistant strains
[0126]
[0127] At the same time, the GOD enzyme activity of the original FG-2 strain was measured to be 147.7683U / ml, and the CAT enzyme activity was 8.473U / ml. According to the results in Table 1-2, the enzyme activity of FG-2-BleoR-GOD-CAT was the highest when the concentration of bleomycin was 300μg / ml, and the GOD enzyme activity reached a maximum of 2099.87U / mL, which was 1321.1% higher than the original, and the CAT reached a maximum of 90.54U / mL, which was 1004.12% higher than the original; the enzyme activity of the FG-2-G418-GOD-CAT recombinant strain was the highest when the concentration of geneticin was 300μg / ml, and the GOD reached a maximum of 1591.93U / ml, which was 977.35% higher than the original, and the CAT reached a maximum of 79.19U / mL, which was 834.62% higher than the original.
[0128] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A method for efficiently producing glucose oxidase in Aspergillus niger by synergistically high expression of GOD and CAT, characterized in that: The specific steps are as follows: (1) Construction of recombinant vectors pAN7-1-BleoR and pAN7-1-G418 ① Using the BleoR gene fragment as a template and primers BleoR-f / r for PCR amplification, the target gene fragment BleoR was obtained; using the G418 gene fragment as a template and primers G418-f / r for PCR amplification, the target gene fragment G418 was obtained; The BleoR gene fragment is shown in SEQ ID NO.9; the G418 gene fragment is shown in SEQ ID NO.10; ②Using plasmid pAN7-1 as template, PCR amplification was performed using primers BleoR-zai-f / r to obtain the vector backbone pAN7-1 corresponding to BleoR; PCR amplification was performed using G418-zai-f / r to obtain the vector backbone pAN7-1 corresponding to G418; ③ The target gene fragment obtained in step ① and the vector backbone obtained in step ② were digested with the rapid endonuclease DpnI respectively, and then cloned and connected in one step to obtain the recombinant vectors pAN7-1-BleoR and pAN7-1-G418; (2) Construction of recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT ①Using the genome extracted from Aspergillus niger FG-2 as a template, PCR amplification was performed using primers GOD-f / r to obtain the GOD gene fragment; ② Using the recombinant vectors pAN7-1-BleoR and pAN7-1-G418 obtained in step (1) as templates, PCR amplification was performed using primers GOD-zai-f / r to obtain vector backbones pAN7-1-BleoR and pAN7-1-G418; ③ The GOD gene fragment obtained in step ① and the linearized vector obtained in step ② were digested with the rapid endonuclease DpnI, and then cloned and connected in one step to obtain the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD; ④ Using the recombinant plasmids pAN7-1-BleoR-GOD and pAN7-1-G418-GOD as templates, PCR amplification was performed using primers p2a-f / r to obtain linearized recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD; ⑤ The linearized recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD obtained in step ④ were digested with the rapid endonuclease DpnI, and the linearized recombinant vectors were self-ligated by a one-step cloning method to obtain pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a; ⑥Using the genome of Aspergillus niger FG-2 as a template, PCR amplification was performed using primers CAT-f / r to obtain the CAT gene fragment; ⑦ Using the recombinant plasmids pAN7-1-BleoR-GOD-p2a and pAN7-1-G418-GOD-p2a as templates, PCR amplification was performed using primers CAT-zai-f / r to obtain the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD to which the CAT gene fragments to be connected; ⑧ The recovered vector backbone and gene fragment were digested with the rapid endonuclease DpnI, and the recombinant vectors pAN7-1-BleoR-GOD and pAN7-1-G418-GOD were connected with the CAT gene fragment respectively by a one-step cloning method to obtain the recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT; (3) Using Aspergillus niger FG-2 as the starting strain, the recombinant vectors pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT were expressed The recombinant plasmids pAN7-1-BleoR-GOD-p2a-CAT and pAN7-1-G418-GOD-p2a-CAT were transformed into FG-2, respectively, and the genetically engineered strains FG-2-BleoR-GOD-CAT and FG-2-G418-GOD-CAT were obtained by antibiotic pressure screening.
2. The method for efficiently producing glucose oxidase by synergistically highly expressing GOD and CAT in Aspergillus niger according to claim 1, characterized in that: The primer sequences used in step (1) are as follows: BleoR-zai-f: 5'-tgaagtagatgccgaccgcgggatc-3'; SEQ ID NO.1; BleoR-zai-r: 5'-catggtgatgtctgctcaagcggggt-3'; SEQ ID NO.2; G418-zai-f: 5'-taaagtagatgccgaccgcgggatc-3'; SEQ ID NO.3; G418-zai-r: 5'-catggtgatgtctgctcaagcggggt-3'; SEQ ID NO.4; BleoR-f: 5'-gagcagacatcaccatggccaagttgaccagtgccgttccggt-3'; SEQ ID NO.5; BleoR-r: 5'-ggtcggcatctacttcagtcctgctcctcggccacgaagt-3'; SEQ ID NO.6; G418-f: 5'-gagcagacatcaccatgagccatsttcaacggga-3'; SEQ ID NO.7; G418-r: 5'-ggtcggcatctactttagaaaaactcatcgagcatcaaat-3'; SEQ ID NO.
8.
3. The method for efficiently producing glucose oxidase by synergistically high expression of GOD and CAT in Aspergillus niger according to claim 1, characterized in that: The primer sequences used in step (2) are as follows: GOD-f: 5'-ctctttcttttcccctgccacactacatcaggagcaatg-3'; SEQ ID NO.11; GOD-r: 5'-aatatactgaagatctgcatagaagcgtagtcctccaaaatag-3'; SEQ ID NO. 12; GOD-zai-f: 5'-cagatcttcagtatattcatcttcccatcca-3'; SEQ ID NO.13; GOD-zai-r: 5'-caggggaaaagaaagagaaaagaaaagagca-3'; SEQ ID NO.14; p2a-f: 5'-ctgaagcaggccggcgacgtggaggagaaccccggccccatcttcagtatattcatctt-3'; SEQ ID NO.15; p2a-r: 5'-tcgccggcctgcttcagcagggagaagttggtggcctgcactagaagcgtagtcctc-3'; SEQ ID NO.16; CAT-f: 5'-agaaccccggccccatgggcaaggacgatcaacccaagac-3'; SEQ ID NO. 18; CAT-r: 5'-aatatactgaagatttacagacgagcagacttggagtgg-3'; SEQ ID NO.19; CAT-zai-f: 5'-taaatcttcagtatattcatcttccc-3'; SEQ ID NO. 20; CAT-zai-r: 5'-catggggccggggttctcct-3'; SEQ ID NO.
21.
4. The method of claim 1, wherein the method comprises: The antibiotic pressure screening in step (3) is screening with 50-1000 μg / ml bleomycin or geneticin.
